相关实验视频
Updated: May 9, 2026

09:04
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
13.4K
在ABO不兼容移植中测定抗体标位的不同方法的评估
Shanshan Zhou1, Qian Liu2, Man Fang1
1Blood Transfusion Department, The First Affiliated Hospital of University of Science and Technology of China (USTC), Hefei, China.
Translational andrology and urology
|April 14, 2025
概括
选择正确的血液检测方法是ABO不兼容移植的关键. 微柱凝卡测试 (MGT) 是推用于监测移植后的抗体标位.
科学领域:
- 移植免疫学 移植免疫学
- 临床实验室科学 临床实验室科学
背景情况:
- 血液型抗体中介排斥是ABO不兼容移植的一个主要障碍.
- 标准化抗体检测方法和基线对于安全的ABO不兼容脏全移植至关重要.
- 目前抗体检测方法的差异阻碍了建立统一的基线标位.
研究的目的:
- 为了比较不同抗体标位检测方法对ABO不兼容的移植接受者.
- 为了指导选择适当的抗体标位检测方法.
- 为了建立ABO抗体标位的合理基线.
主要方法:
- 分析了210个EDTA抗凝血血液样本,这些样本来自接受了ABO不兼容移植的患者.
- 使用管试验 (TT),微柱凝卡试验 (MGT) 和玻璃珠卡试验 (GBT) 测量免疫球蛋白M (IgM) 和免疫球蛋白G (IgG) ABO抗体标位.
主要成果:
- 与MGT相比,通过TT的IgM标位显示出最小的变化 (<1稀释),但与GBT相比,有2-4稀释的差异.
- 根据MGT的IgG标位始终比TT高出一个稀释.
- TT和GBT显示了IgG标位的2-3个连续稀释差异.
结论:
- 对于临床实验室来说,一致使用单一的测试方法和清晰的报告是必不可少的.
- 微柱凝卡测试 (MGT) 是有效的监测移植后抗体标位变化.
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

